Ionis Pharmaceuticals, Inc. (IONS) scores 43 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $111.13, representing a 36% margin of safety.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.